ED vs SER · P/E 18, rev $15.26B vs rev $56.0K
Consolidated Edison Inc (ED) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
ED currently screens at market cap $36.02B and trailing P/E 18.3. SER currently screens at market cap $29.7M.
Not investment advice. Open the ED and SER stock pages for the full models.
Not investment advice.